Azzad Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.45M | Buy |
32,691
+215
| +0.7% | +$41.5K | 0.65% | 23 |
|
|
2025
Q4 | $5.97M | Buy |
32,476
+119
| +0.4% | +$20.9K | 0.59% | 32 |
|
|
2025
Q3 | $4.96M | Buy |
32,357
+184
| +0.6% | +$27.8K | 0.49% | 47 |
|
|
2025
Q2 | $4.5M | Buy |
32,173
+609
| +2% | +$85.4K | 0.48% | 45 |
|
|
2025
Q1 | $4.64M | Buy |
31,564
+448
| +1% | +$64.8K | 0.55% | 42 |
|
|
2024
Q4 | $4.08M | Buy |
31,116
+569
| +2% | +$79.7K | 0.79% | 29 |
|
|
2024
Q3 | $4.76M | Sell |
30,547
-351
| -1% | -$56.7K | 0.53% | 43 |
|
|
2024
Q2 | $4.82M | Sell |
30,898
-228
| -0.7% | -$34.3K | 0.57% | 33 |
|
|
2024
Q1 | $4.22M | Buy |
31,126
+982
| +3% | +$130K | 0.49% | 56 |
|
|
2023
Q4 | $4.06M | Buy |
30,144
+273
| +0.9% | +$35.5K | 0.51% | 49 |
|
|
2023
Q3 | $4.05M | Buy |
29,871
+377
| +1% | +$51.5K | 0.57% | 40 |
|
|
2023
Q2 | $4.22M | Sell |
29,494
-5,194
| -15% | -$764K | 0.57% | 42 |
|
|
2023
Q1 | $4.82M | Buy |
34,688
+364
| +1% | +$49K | 0.69% | 27 |
|
|
2022
Q4 | $4.65M | Sell |
34,324
-11,255
| -25% | -$1.41M | 0.74% | 21 |
|
|
2022
Q3 | $4.97M | Buy |
45,579
+856
| +2% | +$109K | 0.5% | 54 |
|
|
2022
Q2 | $5.71M | Buy |
44,723
+12,874
| +40% | +$1.69M | 0.57% | 36 |
|
|
2022
Q1 | $4.23M | Buy |
31,849
+4,023
| +14% | +$482K | 0.61% | 34 |
|
|
2021
Q4 | $3.24M | Buy |
27,826
+15,192
| +120% | +$1.79M | 0.43% | 69 |
|
|
2021
Q3 | $1.52M | Buy |
12,634
+792
| +7% | +$92.2K | 0.22% | 171 |
|
|
2021
Q2 | $1.42M | Buy |
11,842
+212
| +2% | +$23.3K | 0.21% | 189 |
|
|
2021
Q1 | $1.16M | Buy |
11,630
+3,619
| +45% | +$364K | 0.19% | 196 |
|
|
2020
Q4 | $801K | Buy |
8,011
+232
| +3% | +$24.6K | 0.15% | 213 |
|
|
2020
Q3 | $853K | Buy |
7,779
+350
| +5% | +$38.9K | 0.18% | 185 |
|
|
2020
Q2 | $786K | Sell |
7,429
-51
| -0.7% | -$5.27K | 0.18% | 177 |
|
|
2020
Q1 | $668K | Sell |
7,480
-7,190
| -49% | -$677K | 0.19% | 179 |
|
|
2019
Q4 | $1.51M | Buy |
14,670
+39
| +0.3% | +$3.67K | 0.18% | 185 |
|
|
2019
Q3 | $1.43M | Buy |
14,631
+2,738
| +23% | +$237K | 0.18% | 189 |
|
|
2019
Q2 | $982K | Sell |
11,893
-13
| -0.1% | -$1.02K | 0.27% | 149 |
|
|
2019
Q1 | $963K | Buy |
11,906
+119
| +1% | +$9.38K | 0.28% | 139 |
|
|
2018
Q4 | $895K | Sell |
11,787
-311
| -3% | -$24.3K | 0.3% | 134 |
|
|
2018
Q3 | $957K | Buy |
12,098
+151
| +1% | +$11.4K | 0.26% | 151 |
|
|
2018
Q2 | $839K | Buy |
11,947
+257
| +2% | +$18.5K | 0.24% | 162 |
|
|
2018
Q1 | $818K | Buy |
11,690
+1,174
| +11% | +$81.3K | 0.25% | 154 |
|
|
2017
Q4 | $730K | Buy |
10,516
+610
| +6% | +$41.1K | 0.23% | 158 |
|
|
2017
Q3 | $671K | Buy |
+9,906
| New | +$626K | 0.22% | 163 |
|
Other funds holding AZN
IA
VCM
VAM
Azzad Asset Management's AZN Position: Q1 2026 in Review
Azzad Asset Management increased its AstraZeneca (AZN) stake by 0.66% in Q1 2026, buying an estimated $41.5K and bringing the position to 32,691 shares worth $6.45M. The position accounts for 0.65% of the portfolio, ranked #23.
Azzad Asset Management first reported a position in AZN in Q3 2017 and has held it in 35 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Azzad Asset Management held 32,691 shares of AstraZeneca worth $6.45M as of Q1 2026.
- Azzad Asset Management bought 215 AstraZeneca shares in Q1 2026, an estimated $41.5K.
- AstraZeneca made up 0.65% of Azzad Asset Management's portfolio in Q1 2026, its #23 holding.
- Azzad Asset Management first reported a position in AstraZeneca in Q3 2017 and has held it in 35 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.